Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study

Published:2021-07 Issue:7 Volume:9 Page:e999-e1008
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Kande Betu Ku Mesu Victor,Mutombo Kalonji Wilfried,Bardonneau Clélia,Valverde Mordt Olaf,Ngolo Tete Digas,Blesson Séverine,Simon François,Delhomme Sophie,Bernhard Sonja,Mahenzi Mbembo Hélène,Mpia Moke Christian,Lumeya Vuvu Steven,Mudji E'kitiak Junior,Akwaso Masa Felix,Mukendi Ilunga Melchias,Mpoyi Muamba Nzambi Dieudonné,Mayala Malu Tim,Kapongo Tshilumbwa Serge,Botalema Bolengi Franck,Nkieri Matsho Mathieu,Lumbala Crispin,Scherrer Bruno,Strub-Wourgaft Nathalie,Tarral Antoine

Funder

Médecins Sans Frontières

Swiss Agency for Development and Cooperation

United Kingdom Department for International Development

Brian Mercer Charitable Trust

Republic and Canton of Geneva

Bill & Melinda Gates Foundation

Norwegian Agency for Development Cooperation

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Epidemiology of human African trypanosomiasis;Franco;Clin Epidemiol,2014

2. A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis;Babokhov;Pathog Glob Health,2013

3. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000–2009: the way forward;Simarro;PLoS Negl Trop Dis,2011

4. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial;Mesu;Lancet,2018

5. Improving the quality of host country ethical oversight of international research: the use of a collaborative ‘pre-review’ mechanism for a study of fexinidazole for human African trypanosomiasis;Coleman;Dev World Bioeth,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SAR Study of 4,8-Disubstituted Pyrimido[5,4-d]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial Activity;ACS Medicinal Chemistry Letters;2024-08-22

2. Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea;PLOS Neglected Tropical Diseases;2024-08-19

3. Engineered In Vitro Models to Improve the Mechanistic Understanding and Treatment of Neglected Tropical Diseases Caused by Protozoan Parasites;GEN Biotechnology;2024-08-09

4. Engineered In Vitro Models to Improve the Mechanistic Understanding and Treatment of Neglected Tropical Diseases Caused by Protozoan Parasites;GEN Biotechnology;2024-08-01

5. Nature-derived Peptides as Promising Antiparasitic Agents against Neglected Tropical Diseases;International Journal of Peptide Research and Therapeutics;2024-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3